Doctors getting biggest payments from drug companies don’t declare them on new websiteBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3679 (Published 01 July 2016) Cite this as: BMJ 2016;354:i3679
Read all the latest BMJ articles on Disclosure UK and view the linked infographics here.
- Nigel Hawkes
Health professionals who are paid the most by UK drug companies for providing time and advice are the least likely to have voluntarily declared the payments, analysis of a new disclosure website indicates.
The data show that 70% of healthcare professionals in receipt of payments from companies required to register details on a website hosted by the Association of the British Pharmaceutical Industry (ABPI) agreed to have the data disclosed. But the 30% who didn’t agree to disclosure received 52% of the payments registered (fig 1⇓). However, The BMJ has been unable so far to determine how many healthcare professionals are included in the website and how many are doctors.
Mike Thomson, chief executive of the association, said that this meant that those receiving the largest payments were less likely to have agreed to have them disclosed. “I’m disappointed by that,” he said. “These are probably leading consultants whose services are highly valued by the companies. It’s understandable that we don’t want our neighbours to know how much we earn, but I hope that when they see this database published they may think …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial